All > Breast

ARM 2 for Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Massachusetts General Hospital/North Shore Cancer Center, Salem, MABreast Cancer+2 MoreCognitive, functional and subjective assessments - Other
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial looks at how well chemotherapy affects cognition and the brain in people with breast cancer.

Eligible Conditions
  • Cognitive Impairment
  • Chemobrain
  • Breast Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
[11C]-NOP46
1
Diagnostic (fluciclovine F18 PET/CT)
1
PET/CT Scan with FNP-59

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Baseline, 6 months after completion of chemotherapy

Month 6
Correlation between baseline amyloid accumulation in the brain and change in cognitive performance
Correlation between baseline tau accumulation in the brain and change in cognitive performance
Correlation between change in tau accumulation in the brain (from baseline to 6 months after completion of chemotherapy) and change in cognitive performance (from baseline to 6 months after completion of chemotherapy)
Month 6
Change in cognitive performance scores

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
[11C]-NOP46
1
Diagnostic (fluciclovine F18 PET/CT)
1
PET/CT Scan with FNP-59

Trial Design

3 Treatment Groups

ARM 2
1 of 3
ARM 3
1 of 3
ARM 1
1 of 3

Active Control

200 Total Participants · 3 Treatment Groups

Primary Treatment: ARM 2 · No Placebo Group · N/A

ARM 2ActiveComparator Group · 3 Interventions: Cognitive, functional and subjective assessments, PET Scan, MRI · Intervention Types: Other, Radiation, Device
ARM 3ActiveComparator Group · 3 Interventions: Cognitive, functional and subjective assessments, PET Scan, MRI · Intervention Types: Other, Radiation, Device
ARM 1ActiveComparator Group · 3 Interventions: Cognitive, functional and subjective assessments, PET Scan, MRI · Intervention Types: Other, Radiation, Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 6 months after completion of chemotherapy

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,725 Previous Clinical Trials
31,222,184 Total Patients Enrolled
78 Trials studying Breast Cancer
125,318 Patients Enrolled for Breast Cancer
Michael Parsons, PhDPrincipal InvestigatorMassachusetts General Hospital

Eligibility Criteria

Age 18+ · Female Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Are there still openings to participate in this research trial?

"It appears that this clinical trial is still open for recruitment, as the information posted on clinicaltrials.gov has been recently updated (January 19th 2021). The research was initially published March 1st 2015." - Anonymous Online Contributor

Unverified Answer

What is the upper limit on participants taking part in this experiment?

"Affirmative. Clinicaltrials.gov attests that this clinical trial, which was initially published on March 1st 2015 is currently recruiting participants. 200 patients need to be enrolled from 2 distinct medical facilities." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top